NEXT GENERATION SEQUENCING MARKET ANALYSIS

Next Generation Sequencing Market, By Product Type (Instruments, Reagents & Consumables), By Sequencing Type (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others), By Application (Drug Discovery, Personalized Medicine, Genetic Screening, Diagnostics, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, Clinical Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI158
Pages :156
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges: Complex data integration & management issue

The major factors that hinder growth of the global next generation sequencing market include the storage and management issue of enormous data generated by next generation sequencing and its interpretation. In spite of tremendous advancements to broaden NGS applications from research to clinic, NGS still presents enormous challenges in terms of data storage, processing, quality control management and interpretation, which slow the translation from the bench-top to the bed-side

Market Opportunities: Rise in the research and development activities

The declining cost of sequencing per genome is improving the affordability and allowing new clinical and research applications. The developments in single-cell sequencing and spatial transcriptomics provide new opportunities in precision medicine and disease research. Additionally, the sequencing of various genomes is helping in better understanding of thousands of genetic disorders and opening avenues for new treatment development.